A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Preformulation Study of Dolasetron: An Insight for Formulation and Development of Nasal Formulation
2018
American Journal Of Pharmacy And Health Research
The objective of preformulation study is to develop the elegant, stable, effective and safe dosage form by establishing kinetic profile, compatibility with other formulation excipients and to establish physico-chemical parameter of new drug substance. This could provide important information for formulation design or support the need for molecular modification. So, in the present study preformulation studies were performed on Dolasetron (DS) to assess its suitability for nasal formulation. DS
doi:10.46624/ajphr.2018.v6.i10.001
fatcat:fgtegq6ravhepghze62gmqkv4q